SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-17-031894
Filing Date
2017-05-11
Accepted
2017-05-11 16:02:57
Documents
1
Period of Report
2017-05-09

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 7732
  Complete submission text file 0001104659-17-031894.txt   9393
Mailing Address 887 GREAT NORTHERN WAY SUITE 250 VANCOUVER A1 V5T 4T5
Business Address 887 GREAT NORTHERN WAY SUITE 250 VANCOUVER A1 V5T 4T5 6047077000
NOVELION THERAPEUTICS INC. (Issuer) CIK: 0000827809 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10835 ROAD TO THE CURE SUITE 205 SAN DIEGO CA 92121
Business Address
Szela Mary T (Reporting) CIK: 0001410289 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-17082 | Film No.: 17834212